Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6Zhuoxian Cao, Bin He, Zhicheng Gu et al.|ACS Chemical Biology|2021Cited by 64
Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating CancerZhuoxian Cao, Bin He, Fen‐Fen Yang et al.|Journal of Medicinal Chemistry|2021Cited by 57
Antiepileptic Drug Combinations for Epilepsy: Mechanisms, Clinical Strategies, and Future ProspectsCunjiang Li, Bin He, Xingyu Wang et al.|International Journal of Molecular Sciences|2025Cited by 32
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer’s diseaseYan Li, Bin He, Shuxian Lin et al.|Bioorganic & Medicinal Chemistry Letters|2022Cited by 30
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s DiseaseYan Li, Bin He, Zhicheng Gu et al.|Brain Sciences|2022Cited by 29